[The treatment of idiopathic pulmonary artery hypertension and its relation to systemic scleroderma].
Humbert
M
M
Centre des maladies vasculaires pulmonaires, UPRES EA 2705, service de pneumologie et réanimation respiratoire, hôpital Antoine-Béclère, AP-HOP, université Paris-Sud, 157 rue de la Porte-de-Trivaux, 92140 Clamart, France. marc.humbert@abc.ap-hop-paris.fr
D015106:3',5'-Cyclic-GMP Phosphodiesterases / Q000037:antagonists & inhibitors; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000077300:Bosentan; D065128:Endothelin Receptor Antagonists; D011464:Epoprostenol / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D006976:Hypertension, Pulmonary / Q000150:complications / Q000188:drug therapy*; D016285:Iloprost / Q000627:therapeutic use; D007275:Injections, Intravenous; D010726:Phosphodiesterase Inhibitors / Q000627:therapeutic use; D010879:Piperazines / Q000627:therapeutic use; D011687:Purines / Q000627:therapeutic use; D012595:Scleroderma, Systemic / Q000150:complications*; D000068677:Sildenafil Citrate; D013449:Sulfonamides / Q000627:therapeutic use; D013450:Sulfones / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use
D000959:Antihypertensive Agents; D065128:Endothelin Receptor Antagonists; D010726:Phosphodiesterase Inhibitors; D010879:Piperazines; D011687:Purines; D013449:Sulfonamides; D013450:Sulfones; D014665:Vasodilator Agents; D000068677:Sildenafil Citrate; D011464:Epoprostenol; D015106:3',5'-Cyclic-GMP Phosphodiesterases; D016285:Iloprost; D000077300:Bosentan